Wed, February 4, 2009
Tue, February 3, 2009
Mon, February 2, 2009
Sun, February 1, 2009
Sat, January 31, 2009
Fri, January 30, 2009
[ Fri, Jan 30th 2009 ] - Market Wire
Progen-Avexa Merger Update
Thu, January 29, 2009
Wed, January 28, 2009
Tue, January 27, 2009
[ Tue, Jan 27th 2009 ] - Market Wire
SCOR: SCOR sets up Zurich Hub
Mon, January 26, 2009
Sun, January 25, 2009
Fri, January 23, 2009
Thu, January 22, 2009
Wed, January 21, 2009

Watson Pharmaceuticals: Watson to Host Fourth Quarter and Full Year 2008 Earnings Conference Call and Webcast


//health-fitness.news-articles.net/content/2009/ .. r-2008-earnings-conference-call-and-webcast.html
Published in Health and Fitness on Thursday, January 29th 2009 at 6:03 GMT, Last Modified on 2009-01-29 06:04:28 by Market Wire   Print publication without navigation


CORONA, CA--(Marketwire - January 29, 2009) - Watson Pharmaceuticals, Inc. (NYSE: [ WPI ]), a leading specialty pharmaceutical company, announced today that the Company intends to release its fourth quarter and full year 2008 financial results on Thursday, February 19, 2009 prior to the open of the U.S. financial markets. The Company will also host a conference call and webcast at 8:30 a.m. Eastern Standard Time on February 19, 2009 to discuss its financial results and provide an outlook for 2009. The dial-in number to access the call is (877) 251-7980, or from international locations, (706) 643-1573.

A taped replay of the conference call will also be available beginning approximately two hours after the call's conclusion and will remain available through 12:00 midnight Eastern Standard Time on February 27, 2009. The replay may be accessed by dialing (800) 642-1687 and entering pass code 82174623. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same pass code. To access the webcast, go to Watson's Investor Relations Web site at [ http://ir.watson.com ]. A replay of the webcast will also be available.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

For press releases and other company information, visit Watson Pharmaceuticals' Web site at [ http://www.watson.com ].


Publication Contributing Sources